title: [Impact of olmesartan medoxomil on atherosclerosis lesions in apolipoprotein E knockout mice].
abstract: OBJECTIVE
  To investigate the effect and possible mechanisms of olmesartan medoxomil on atherosclerosis of apolipoprotein E knockout (ApoE(-/-)) mice.
  
  
  METHODS
  Sixteen 6-week-old male ApoE(-/-) mice were randomly divided into atherosclerosis model group fed with high fat diet, and olmesartan medoxomil intervention group fed with high fat diet and olmesartan medoxomil (10 mg·kg(-1)·day(-1,) per gavage). Eight C57BL/6 mice were fed with normal diet, and treated for 12 weeks.The blood pressure and the serum level of lipid were detected; the aorta were removed, oil red staining for plaque area, Hematoxylin and eosin (HE) staining for plaque morphology, Elastica van Gieson (EVG) staining for elastin, and picrosirius red (PSR) for collagen respectively; and the expression of cathepsin S (Cat S), smooth action protein (ASMA) and macrophage surface molecule-3 (Mac-3) were detected by immunohistochemisty analysis.
  
  
  RESULTS
  Serum cholesterol and low density lipoprotein levels were significantly higher in atherosclerosis model group than in control group[(15.08±1.64) vs (2.06±0.15) mmol/L, (15.60±1.05) vs (0.00±0.00) mmol/L] (all P<0.01), while triglyceride level was similar between the two group.In contrast to model group, the mice in intervention group showed no statistical difference in blood pressure and plasma lipid levels, while the plaque areas in the aorta were significantly decreased (P<0.05) as well as the expression of Cat S and Mac-3[(2.4±1.2) vs (8.8±3.2)%, (2.2±1.2) vs (7.2±2.8)%] (all P<0.01). In addition, the elastin levels, collagen contents, and the expression of ASMA remained significantly higher compared with model group (P<0.05).
  
  
  CONCLUSIONS
  Olmesartan medoxomil could slow down the atherosclerosis process, the possible mechanism was implicated with the suppression of Cat S and decreased inflammatory responses alongside the increased elastin and collagen contents.
authors: Department of Cardiology, the First Affiliated Hospital of China Medical University, Shenyang 110001, China.
authors: H
authors: H
authors: Li
authors: L Y
authors: LY
authors: Shi
authors: L
authors: L
authors: Chen
authors: Y Z
authors: YZ
authors: Lu
authors: B
authors: B
authors: Yu
authors: G X
authors: GX
authors: Qi
mesh_terms: D000818:Animals; D001011:Aorta; D001057:Apolipoproteins E; D050197:Atherosclerosis; D002403:Cathepsins; D059305:Diet, High-Fat; D008055:Lipids; D008264:Macrophages; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D000068557:Olmesartan Medoxomil; D058226:Plaque, Atherosclerotic
chemical_list: D001057:Apolipoproteins E; D008055:Lipids; D000068557:Olmesartan Medoxomil; D002403:Cathepsins; C028217:cathepsin S